180
Participants
Start Date
February 28, 2005
Primary Completion Date
November 30, 2005
Study Completion Date
November 30, 2005
aliskiren
Investigative Site, Berlin
Investigative Site, Budapest
Investigative Site, Madrid
Novartis Pharmaceuticals, Basel
Lead Sponsor
Novartis
INDUSTRY